Tamoxifen exposure during pregnancy; A Case report and review of the literature
    PDF
    Cite
    Share
    Request
    Case Report
    P: 168-170
    September 2008

    Tamoxifen exposure during pregnancy; A Case report and review of the literature

    J Turk Ger Gynecol Assoc 2008;9(3):168-170
    1. Department Of Obstetrics And Gynecology, Faculty Of Medicine, Akdeniz University, Antalya, Turkey
    No information available.
    No information available
    Received Date: 08.03.2008
    Accepted Date: 12.08.2008
    PDF
    Cite
    Share
    Request

    ABSTRACT

    Breast cancer is the most frequent cancer type in women in the world. It is treated by surgery, chemotherapy, radiation therapy or in combination of these modalities. For the adjuvant treatment, tamoxifen is used widely. Pregnancy can occur during tamoxifen treatment in the premenoposal patients. But, there is no sufficient data safety of tamoxifen during pregnancy. So, here we presented the case using tamoxifen until 16 weeks of pregnancy. She was followed and delivered at the 38th weeks of pregnancy. No fetal anomalies have been observed in this case for three years. In the review of the literature addressing tamoxifen exposure during pregnancy, many studies are experimental and there are a few reports about pregnancy in human. Tamoxifen may be potentionally teratogenic, but frequently, this effect is not observed in human. So, tamoxifen exposure during pregnancy may not have a serious effect on the fetus.

    Keywords: Tamoxifen, Pregnancy, Breast Cancer

    References

    2024 ©️ Galenos Publishing House